2019-10-23T15:41:46-05:00 2019-03-31 111986323 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2018-04-01 760514428 MELANOMA RESEARCH FOUNDATION MELA 8006731290 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 KYLEIGH LIPIRA CEO 8006731290 2019-10-23 1 FRANK H SMITH P00639053 2022274000 2019-10-23 47.19.127.190 2019-10-23 15:41:43 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 6680F517A9379D01A5AB98078416092631D16800 2018 2020-01-14 16:20:31Z X KYLEIGH LIPIRA 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 5609808 0 X WWW.MELANOMA.ORG X 1996 TX FUND RESEARCH; EDUCATE PATIENTS, CAREGIVERS AND PHYSICIANS; ADVOCATE FOR THE MELANOMA COMMUNITY. 15 14 20 1000 0 8036 5909277 5290886 0 0 56 729 -15712 60616 5893621 5352231 1084651 1231276 0 0 1438860 1372495 106400 122700 424840 2002099 2080796 4632010 4807267 1261611 544964 1498984 1963873 1531481 1445823 -32497 518050 THE MRF IS THE LARGEST INDEPENDENT ORGANIZATION DEVOTED TO MELANOMA. ITS MISSION IS TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING TO AND ADVOCATING FOR THE MELANOMA COMMUNITY. 0 0 1665070 1231276 THE MRF IS COMMITTED TO ADVANCING A BROAD SCIENTIFIC AGENDA ACROSS THE DISCIPLINES OF PREVENTION, DIAGNOSIS AND TREATMENT. ALTHOUGH THE MRF HAS ACHIEVED A NUMBER OF IMPORTANT SCIENTIFIC MILESTONES, MUCH MORE WORK REMAINS TO BE DONE. TO THIS END, THE MRF FUNDS A SPECTRUM OF RESEARCH GRANTS, SCIENTIFIC INITIATIVES, AND PROGRAMS FOR CUTANEOUS MELANOMA AND RARER MELANOMA SUBTYPES (E.G. OCULAR, PEDIATRIC, ACRAL AND MUCOSAL MELANOMA). ITS RESEARCH GRANT PROGRAM IS A COMPETITIVE, PEER-REVIEWED RESEARCH GRANT PROGRAM FOR INVESTIGATOR-INITIATED RESEARCH HAS BEEN IN EXISTENCE SINCE 1998. MRF-SUPPORTED RESEARCH IS OPEN TO MEDICAL STUDENTS THROUGH SENIOR INVESTIGATIVE TEAMS AND ENCOMPASS. 1365212 THE MRF HAS A ROBUST EDUCATION PROGRAM AIMED AT EDUCATING PATIENTS AND PHYSICIANS ABOUT THE PREVENTION, DIAGNOSIS AND TREATMENT OF MELANOMA, AS WELL AS INCREASING OVERALL AWARENESS OF THE DISEASE. IN ADDITION, THE MRF MAINTAINS A LARGE PORTFOLIO OF FREE EDUCATIONAL MATERIALS THAT CAN BE USED AT FUNDRAISERS, DOCTORS' OFFICES, SCHOOLS AND HEALTH FAIRS.PART OF THE MRF'S EDUCATIONAL OFFERINGS ALSO INCLUDE PATIENT-FOCUSED EDUCATIONAL SYMPOSIA THROUGHOUT THE U.S., IMPACTING NEARLY 1,400 PEOPLE TOUCHED BY MELANOMA. THESE SYMPOSIA PROVIDE MELANOMA PATIENTS AND THE PEOPLE WHO SUPPORT THEM THE OPPORTUNITY TO LEARN FROM LEADING MELANOMA EXPERTS ON THE MOST CURRENT PREVENTION, DIAGNOSIS, TREATMENT AND RESEARCH INFORMATION. 985483 THE MRF'S ADVOCACY PROGRAM IS A PLATFORM FOR THOSE AFFECTED BY MELANOMA TO SHARE THEIR VOICE AND TRANSFORM MELANOMA CARE. PATIENTS, CAREGIVERS, SURVIVORS, HEALTHCARE PROFESSIONALS AND PARTNERS ALL PLAY A CRITICAL ROLE IN THE ADVANCEMENT OF BETTER OUTCOMES FOR THE OVER ONE MILLION AMERICANS LIVING WITH MELANOMA AND THEIR LOVED ONES. 4015765 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1 1 0 0 0 0 1 1 1 0 0 1 25 0 1 20 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 X 15 14 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN MS NC ND NH NJ NM NY OH OK OR PA RI UT VA WA WI WV TN SC X KYLEIGH LIPIRA 8006731290 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 STEVE SILVERSTEIN CHAIR 2.00 1.00 X X 0 0 0 JEFFREY HARRIS VICE CHAIR 2.00 X X 0 0 0 GEORGE P JAMESON TREASURER 2.00 X X 0 0 0 JOSEPH FAZIO SECRETARY 2.00 X X 0 0 0 STAN ADLER BOARD MEMBER 1.00 X 0 0 0 CARLTON AMDAHL BOARD MEMBER- UNTIL 12/2018 1.00 X 0 0 0 MANUEL AMEZCUA BOARD MEMBER 1.00 X 0 0 0 MICHAEL B ATKINS MD BOARD MEMBER 1.00 1.00 X 0 0 0 DOUGLAS BROADMAN BOARD MEMBER 1.00 X 0 0 0 REBECCA K DREMAN BOARD MEMBER 1.00 X 0 0 0 TUCKER ESKEW BOARD MEMBER- UNTIL 12/2018 1.00 X 0 0 0 ANTHONY T HENDRICKSON BOARD MEMBER 1.00 1.00 X 0 0 0 CHAD MACDONALD BOARD MEMBER- UNTIL 12/2018 1.00 X 0 0 0 ALISON MARTIN BOARD MEMBER 1.00 1.00 X 0 0 0 GLENN MERINO BOARD MEMBER 1.00 X 0 0 0 WILLIAM G REILLY BOARD MEMBER 1.00 X 0 0 0 ZE'EV A RONAI PHD BOARD MEMBER- UNTIL 12/2018 1.00 1.00 X 0 0 0 CHERYL STRATOS BOARD MEMBER 1.00 X 0 0 0 MARK WEINZIERL BOARD MEMBER 1.00 X 0 0 0 KYLEIGH LIPIRA CEO 40.00 X 177750 0 7743 SUSAN M DORSEY CPA CONTROLLER 40.00 X 127140 0 5433 BETH ALLGAIER DIRECTOR, CORPORATE RELATIONS 40.00 X 121302 0 17593 426192 0 30769 3 0 1 0 POWERED BY PROFESSIONALS 1460 BROADWAY NEW YORK NY 10026 FUNDRAISING SERVICES 223201 JONES PUBLIC AFFAIRS 1420 K STREET NW SUITE 1050 WASHINGTON DC 20005 COMMUNICATIONS 112725 2 155970 1353420 3781496 43373 5290886 123 123 25606 25000 606 606 606 291404 1353420 232577 58827 58827 MERCHANDISE 452000 1233 1233 OTHER 900099 556 556 1789 5352231 0 0 61345 X 1198276 1198276 33000 33000 190435 34279 156156 1020080 902977 115675 1428 23476 21040 2436 33959 27892 4220 1847 104545 78487 12913 13145 3017 3017 61388 55484 5904 102325 102325 122700 122700 554320 525627 28693 61561 41992 14539 5030 295092 255546 15778 23768 233384 159192 55123 19069 102439 75779 14704 11956 220964 189795 12067 19102 358091 317538 5149 35404 21201 15683 3043 2475 15962 8470 7492 RECRUITMENT 19335 14516 2388 2431 REGISTRATION FEES 15173 80 12732 2361 BAD DEBT EXPENSES 15000 0 15000 0 RECOGNITION/AWARDS 1160 536 148 476 384 384 4807267 4015765 366662 424840 594522 873558 3004 15006 653708 638448 0 3250 159770 291593 483151 392998 12374 90153 19535 51865 56071 0 1498984 1963873 166808 244588 1112500 1000000 252173 201235 1531481 1445823 X -2134141 -1236576 2101644 1754626 -32497 518050 1498984 1963873 X 544964 -298 5881 X 0 1 X 1 0 X 385408 5736841 5651905 5873258 5290886 22938298 385408 5736841 5651905 5873258 5290886 22938298 1377453 21560845 68 145 29 56 123 421 3989 8152 2552 1789 16482 22955201 716302 0.93930 0.94590 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER - 2014 AMOUNT: $ 0. 2015 AMOUNT: $ 3,989. 2016 AMOUNT: $ 8,152. 2017 AMOUNT: $ 2,552. 2018 AMOUNT: $ 1,789. 1 1 0 0 0 0 1 3023 1 39111 1 60191 102325 0 PART II-B, LINE 1: A LOBBY FIRM IS RETAINED TO ASSIST WITH DEVELOPING, COORDINATING AND IMPLEMENTING AN ALL-ENCOMPASSING ADVOCACY PROGRAM WHICH INCLUDES BUT IS NOT LIMITED TO FEDERAL FUNDING FOR MELANOMA RESEARCH, ISSUES RELATED TO ADOLESCENTS AND YOUNG ADULTS, PEDIATRIC PATIENTS, RARE MELANOMA SUBTYPES, ACCESS TO CARE, PREVENTION AND SURVIVORSHIP. 5690 5280 410 446974 359614 87360 30487 28104 2383 90153 DEFERRED RENT 2436 DUE TO AFFILIATE 198799 201235 X PART X, LINE 2: MRF PERFORMED AN EVALUATION OF UNCERTAIN IN INCOME TAXES FOR THE YEAR ENDED MARCH 31, 2019, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. X X X X X X 1 POWERED BY PROFESSIONALS 1375 BROADWAY NEW YORK NY 10018 NEW YORK/ PHILADELPHIA GALA 0 1197403 119000 1078403 MDN PRODUCTION 2432 S DOWNING STREET SUITE 202 DENVER CO 80210 DENVER GALA 0 218971 3700 215271 1416374 122700 1293674 AK AL AR AZ CA CO CT FL GA HI IL KS KY NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV ME MD MS MA MI MN DC GALA - NEW YORK 1000007 935633 64374 0 0 19881 50102 1463 17050 GALA - CHICAGO 228450 182655 45795 0 0 13756 19236 0 16868 2 416367 235132 181235 0 0 9639 52743 0 31839 1644824 1353420 291404 43276 122081 1463 65757 232577 58827 1 FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 191112434 236296135 501(C)(3) 200000 TO SUPPORT RESEARCH FOR MELANOMA CANCER UNIVERSITY OF TOLEDO PO BOX 72372 CLEVELAND OH 44192 346401483 501(C)(3) 200000 TO SUPPORT RESEARCH FOR MELANOMA CANCER WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 455 MAIN STREET CAMBRIDGE MA 021421479 061043412 501(C)(3) 200000 TO SUPPORT RESEARCH FOR MELANOMA CANCER YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 065081873 060646973 501(C)(3) 100000 TO SUPPORT RESEARCH FOR MELANOMA CANCER HLEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 200000 TO SUPPORT RESEARCH FOR MELANOMA CANCER DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE 451 BOSTON MA 022155450 042263040 501(C)(3) 100000 TO SUPPORT RESEARCH FOR MELANOMA CANCER OREGON HEALTH & SCIENCE UNIVERSITY 0690 SW BANCROFT STREET PORTLAND OR 972394244 931176109 501(C)(3) 100000 TO SUPPORT RESEARCH FOR MELANOMA CANCER SOCIETY OF MELANOMA RESEARCH PO BOX 113 CLIFTON NY 12065 810638480 501(C)(3) 10000 TO SUPPORT RESEARCH FOR MELANOMA CANCER MELANOMA RESEARCH FOUNDATION 1411 K STREET SUITE 800 WASHINGTON DC 20005 800671049 501(C)(3) 60277 TO SUPPORT RESEARCH FOR MELANOMA CANCER 9 0 STUDENT MEDICAL AWARDS 11 33000 PART I, LINE 2: THE MRF'S SCIENTIFIC LEADERSHIP IS COMPRISED OF MULTIDISCIPLINARY EXPERTS IN BASIC AND TRANSLATIONAL RESEARCH, DERMATOLOGY, EPIDEMIOLOGY, GENOMICS, PATHOLOGY, SURGERY AND MEDICAL ONCOLOGY. MEMBERS OF ALL OUR ADVISORY/ STEERING COMMITTEES ARE VOLUNTEERS THAT ASSIST IN PROVIDING THE SCIENTIFIC DIRECTION OF THE MRF. X X X 0 0 0 0 0 0 0 0 0 KYLEIGH LIPIRA CEO 177750 0 0 0 0 0 5700 0 2043 0 185493 0 0 0 STAN ADLER ASSOCIATES STAN ADLER, BOARD MEMBER, IS ALSO THE CHAIR AND FOUNDER OF THE ASSOCIATES 72000 MRF PAID A RETAINER FEE TO THE ASSOCIATES FOR GRAPHIC DESIGN AND MARKETING SERVICES. 0 X 18320 FMV X 1 25053 FMV 0 0 0 PART I, COLUMN (B): MRF REPORTS THE NUMBER OF CONTRIBUTIONS IN PART I, COLUMN (B). FORM 990, PART VI, SECTION B, LINE 11B THE CONTROLLER AND THE CHIEF EXECUTIVE OFFICER REVIEW THE FEDERAL FORM 990 PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. UPON SUBMISSION OF THE FINAL DRAFT, THE FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS AND THE FINANCE COMMITTEE FOR THEIR REVIEW PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS DISTRIBUTED ANNUALLY TO ALL MEMBERS OF THE BOARD OF DIRECTORS, KEY PERSONNEL, AND COMMITTEE MEMBERS. EACH RECIPIENT OF THE POLICY RETURNS A SIGNED AND DATED RESPONSE FORM INDICATING THEY REVIEWED THE POLICY WHILE NOTING IF ANY CONFLICTS EXIST. FOLLOWING THE FULL DISCLOSURE OF A POSSIBLE CONFLICT OF INTEREST DURING THE YEAR, THE BOARD OF DIRECTORS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS AND THE BOARD MEMBER WITH THE POSSIBLE CONFLICT WILL RECUSE HIMSELF OR HERSELF FROM THE DISCUSSION AND VOTE. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER IS DETERMINED IN THE EXECUTIVE SESSION OF A BOARD OF DIRECTORS MEETING AND IS BASED UPON COMPARABLE SALARY DATA. THE BOARD OF DIRECTORS CONVENES AN AD HOC COMPENSATION COMMITTEE THAT CONTRACTED WITH AN OUTSIDE EXPERT IN SALARY EVALUATION. THIS OUTSIDE GROUP LOOKS AT THE SALARIES OF ALL MRF MANAGEMENT AND COMPARES THOSE SALARIES WITH INDUSTRY STANDARDS, ADJUSTED FOR REGIONAL VARIATIONS. APPROPRIATE ADJUSTMENTS ARE MADE TO ENSURE THAT MRF SALARIES ARE IN KEEPING WITH BEST PRACTICES. THE LAST COMPENSATION REVIEW FOR THE EXECUTIVE DIRECTOR WAS CONDUCTED IN 2016. FORM 990, PART VI, SECTION C, LINE 19 MRF'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G PAYROLL FEES: PROGRAM SERVICE EXPENSES 16,191. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 16,191. TEMPORARY HELP: PROGRAM SERVICE EXPENSES 12,211. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 12,211. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 497,225. MANAGEMENT AND GENERAL EXPENSES 28,693. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 525,918. FORM 990, PART XI, LINE 9: REFUND OF GRANT 5,881. MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC 1411 K STREET SUITE 800 WASHINGTON DC 20005 800671049 TO ORGANIZE, CONDUCT, AND SUPPORT CLINICAL TRIALS DC 501(C)(3) LINE 12A, I MELANOMA RESEARCH FOUNDATION 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC B 60277 COST